Protara Therapeutics, Inc. (TARA)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch TARA
See up to 3 months of TARA. The 7-day demo opens the 1M and 3M ranges and puts TARA on your watchlist.
Start 7-day demoLatest TARA insider trades
About Protara Therapeutics, Inc. (TARA)
Protara Therapeutics, Inc. is an SEC registrant, filing under CIK 0001359931, classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
TARA Form 4 activity by transaction type, last 90 days
No Form 4 activity for TARA in the last 90 days.
TARA insider transactions (Form 4)
4129 Form 4 filings on record, the earliest from Jun 12, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jesse Shefferman - Officer | Option exercise | Common Stock | 215,687 | $1.91 | $412K | |
| Jesse Shefferman - Officer | Gift | Common Stock | 14,000 | $0.00 | - | |
| Jesse Shefferman - Officer | Gift | Common Stock | 7,000 | $0.00 | - | |
| Jesse Shefferman - Officer | Gift | Common Stock | 4,000 | $0.00 | - | |
| Jesse Shefferman - Officer | Gift | Common Stock | 5,000 | $0.00 | - | |
| Jesse Shefferman - Officer | Open-market sale | Common Stock | 215,687 | $4.09 footnote F1 | $882K | |
| Jesse Shefferman - Officer | Option exercise | Stock Option (Right to Buy) | 215,687 | $0.00 | - | |
| ||||||
| Richard S. Levy | Grant or award | Stock Option (Right to Buy) | 31,000 | $0.00 | - | |
| Michael Edward Solomon | Grant or award | Stock Option (Right to Buy) | 31,000 | $0.00 | - | |
| Cynthia Smith | Grant or award | Stock Option (Right to Buy) | 31,000 | $0.00 | - | |
 Gregory Sargen | Grant or award | Stock Option (Right to Buy) | 31,000 | $0.00 | - | |
 Jane Huang | Grant or award | Stock Option (Right to Buy) | 31,000 | $0.00 | - | |
 Roger Garceau | Grant or award | Stock Option (Right to Buy) | 31,000 | $0.00 | - | |
| Barry P. Flannelly | Grant or award | Stock Option (Right to Buy) | 31,000 | $0.00 | - | |
| Luke M. Beshar | Grant or award | Stock Option (Right to Buy) | 31,000 | $0.00 | - | |
| William Conkling - Officer | Tax withholding / forfeiture | Common Stock | 6,008 footnote F1 | $4.34 | $26K | |
| ||||||
| Jacqueline Zummo - Officer | Open-market sale | Common Stock | 1,134 footnote F1 | $5.40 | $6K | |
| ||||||
| Jacqueline Zummo - Officer | Open-market sale | Common Stock | 22,598 footnote F1 | $5.26 footnote F2 | $119K | |
| ||||||
| Hannah Fry - Officer | Tax withholding / forfeiture | Common Stock | 1,457 footnote F1 | $6.67 | $10K | |
| ||||||
 Patrick Fabbio - Officer | Tax withholding / forfeiture | Common Stock | 3,261 footnote F1 | $6.67 | $22K | |
| ||||||
| Jesse Shefferman - Officer | Tax withholding / forfeiture | Common Stock | 8,732 footnote F1 | $6.67 | $58K | |
| ||||||
| Jacqueline Zummo - Officer | Tax withholding / forfeiture | Common Stock | 3,724 footnote F1 | $6.67 | $25K | |
| ||||||
| Jesse Shefferman - Officer | Tax withholding / forfeiture | Common Stock | 16,322 footnote F1 | $5.60 | $91K | |
| ||||||
| Patrick Fabbio - Officer | Tax withholding / forfeiture | Common Stock | 3,063 footnote F1 | $5.60 | $17K | |
| ||||||
| Jacqueline Zummo - Officer | Tax withholding / forfeiture | Common Stock | 6,578 footnote F1 | $5.60 | $37K | |
| ||||||
| Hannah Fry - Officer | Tax withholding / forfeiture | Common Stock | 2,132 footnote F1 | $5.60 | $12K | |
| ||||||
| William Conkling - Officer | Grant or award | Common Stock | 26,000 footnote F1 | $0.00 | - | |
| William Conkling - Officer | Grant or award | Stock Option (Right to Buy) | 158,000 | $0.00 | - | |
| ||||||
| Patrick Fabbio - Officer | Grant or award | Common Stock | 28,000 footnote F1 | $0.00 | - | |
| Patrick Fabbio - Officer | Grant or award | Stock Option (Right to Buy) | 175,000 | $0.00 | - | |
| ||||||
| Hannah Fry - Officer | Grant or award | Common Stock | 9,500 footnote F1 | $0.00 | - | |
| Hannah Fry - Officer | Grant or award | Stock Option (Right to Buy) | 55,000 | $0.00 | - | |
| ||||||
| Leonardo Viana Nicacio - Officer | Grant or award | Common Stock | 26,000 footnote F1 | $0.00 | - | |
| Leonardo Viana Nicacio - Officer | Grant or award | Stock Option (Right to Buy) | 158,000 | $0.00 | - | |
| ||||||
| Jesse Shefferman - Officer | Grant or award | Common Stock | 87,000 footnote F1 | $0.00 | - | |
| Jesse Shefferman - Officer | Grant or award | Stock Option (Right to Buy) | 524,000 | $0.00 | - | |
| ||||||
| Jacqueline Zummo - Officer | Grant or award | Common Stock | 30,000 footnote F1 | $0.00 | - | |
| Jacqueline Zummo - Officer | Grant or award | Stock Option (Right to Buy) | 180,000 | $0.00 | - | |
| ||||||
| Jesse Shefferman - Officer | Gift | Common Stock | 300,000 | $0.00 | - | |
| Gregory Sargen | Grant or award | Stock Option (Right to Buy) | 24,000 | $0.00 | - | |
| Luke M. Beshar | Grant or award | Stock Option (Right to Buy) | 24,000 | $0.00 | - | |
Item 2.02, 9.01
Item 5.02
Item 5.07
Item 2.02, 9.01
Recent TARA Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
TARA insider trading FAQ
What is the latest insider trade for TARA?
Protara Therapeutics, Inc. (TARA) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-07-01. The full record for TARA runs to 29 Form 4 filings, the earliest from 2025-06-12. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TARA stock?
No insider purchases of TARA were filed in the last 90 days.
How many insiders are selling TARA stock?
No insider sales of TARA were filed in the last 90 days. 3 sales are on record for this company.
Where can I see TARA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TARA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jesse Shefferman view on EDGAR
- - Richard S. Levy view on EDGAR
- - Michael Edward Solomon view on EDGAR
- - Cynthia Smith view on EDGAR
- - Gregory Sargen view on EDGAR
- - Jane Huang view on EDGAR
- - Roger Garceau view on EDGAR
- - Barry P. Flannelly view on EDGAR
- - Luke M. Beshar view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where TARA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TARA with a 7-day demo
- TARA on your watchlist
- Every TARA Form 4 filing on record
- Up to 3 months of TARA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
